Combination treatment with trimetazidine and diltiazem in stable angina pectoris

Heart

Volumn 78, Issue 4, 1997, Pages 353-357

  Manchanda, S C ^a   Krishnaswami, S ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Blood pressure; Diltiazem; Stable angina; Treatment; Trimetazidine

Indexed keywords

DILTIAZEM; TRIMETAZIDINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENTIATION; EXERCISE TEST; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; TREATMENT OUTCOME;

EID: 0030703575     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.4.353     Document Type: Article

References (23)

1. Lazar EJ, Frishman WH. Profile of an ideal antianginal agent. Drugs 1989;38(suppl 2):1-8S.
2. Akhras F, Jackson G. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina. Lancet 1991;338:1036-9.
3. McMurray J, Rankin A. Recent advances in cardiology - 1: treatment of myocardial infarction, unstable angina, and angina pectoris. BMJ 1994;309:1343-51.
4. Rao HRG, White JG. Coronary artery disease: an overview of risk factors. Indian Heart J 1993;45:143-53.
5. Robertson RM, Robertson D. Drugs used for the treatment of myocardial ischaemia. In: Hardman IG, Limbird LE, eds. Goodman and Gilman's the pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill, 1996:775-6.
6. Harpey C, Clauser P, Labrid C, Fryria J, Poirier J. Trimetazidine, a cellular anti-ischaemic agent. Cardiovasc Drugs Rev 1989;6:292-312.
7. Sellier P, Audouin P, Payen B, Corona P, Duong TC, Ourbak P. Acute effects of trimetazidine evaluated by exercise testing. Eur J Clin Pharmacol 1987;33:205-7.
8. Dalla-Volta S, Maraglino G, Della-Valentina P, Viena P, Desideri A. Comparison of trimetazidine with nifedipine in effort angina: a double-blind crossover study. Cardiovasc Drugs Ther 1990;14(suppl 4):853-9.
9. Detry JM, Sellier P, Pennaforte S, Cokkinos D, Mathes P. Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Br J Clin Pharmacol 1994;37:279-88.
10. Braunwald E. Examination of the patient, part 1 - the history. In: Braunwald E, ed. Heart disease, a textbook of cardiovascular medicine, 3rd ed. Philadelphia: WB Saunders, 1988;12.
11. Bruce RA, Blackmon JR, Jones JW, Strait G. Exercise testing in adult normal subjects and cardiac patients. Pediatrics 1963;32:742-5.
12. Levy S, and group of South of France investigators. Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. In: Maseri A, ed. From mitochondrial metabolism to coronary artery disease: new trends in management of myocardial ischaemia. Am J Cardiol 1995;76:8-12B.
13. Garcia-Palmieri M. The treatment of stable angina pectoris. Postgrad Med J 1992;68(suppl 1):61-4S.
14. Opie LH. Myocardial ischaemia - metabolic pathways and implications of increased glycolysis. Cardiovasc Drugs Ther 1990;4:777-90.
15. Opie LH. High energy phosphate compounds. In: Rake-Holland AJ, Noble MIM, eds. Cardiac metabolism. New York: John Wiley & Sons, 1983:279-307.
16. Gevers W. Generation of protons by metabolic processes in heart cells. J Mol Cell Cardiol 1977;9:867-74.
17. McCord JM. Oxygen derived free radicals in post-ischaemic tissue injury. N Engl J Med 1985;312:159-63.
18. Rossi A, Lavanchy N, Martin J. Anti-ischaemic effects of trimetazidine: P-NMR spectroscopy study in the isolated rat heart. Cardiovasc Drugs Ther 1990;4:812-3.
19. Maupoil V, Rochette L, Tabard A, Clauser P, Harpey C. Direct measurement of free radical generation in isolated rat heart by electron paramagnetic resonance spectroscopy: effect of trimetazidine. In: Emerit I, ed. Antioxidants in therapy and preventive medicine. New York: Plenum Press, 1990:373-6.
20. Maridonneau P, Harpey C. Trimetazidine protects the human red blood cell against oxygen free radical damage. Cardiovasc Drugs Ther 1990;4:818-9.
21. Fabiani MD, Ponzio O, Emerit I, Massonet-Castel S, Paris M, Chevalier P, et al. Cardioprotective effect of trimetazidine during coronary artery graft surgery. J Cardiovasc Surg 1992;33:486-91.
22. Kober G, Buck T, Sievert H, Vallbracht C. Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine. Eur Heart J 1992;13: 1109-15.
23. Bricaud H, Brottier L, Barat JL, Combe C, Boussens B, Bonnet J. Cardioprotective effect of trimetazidine in severe ischaemic cardiomyopathy. Cardiovasc Drugs Ther 1990;4: 861-6.